Literature DB >> 10798109

Kala azar.

L S Prasad.   

Abstract

Although visceral leishmaniasis (VL) or Kala-azar caused by Leishmania donovani (LD) is globally, a public health problem and its eradication is of high priority, yet until now, no animal reservoir has been found in India and transmission of Kala-azar occurs from man to man through the recognised vector P. argentipes. The cutaneous or dermal leishmaniasis is caused by L. tropica and this is restricted to Rajasthan where it is zoonotic. Investigation by Sharma et al revealed the presence of zoonotic reservoir in Indian desert gerbils, the rodent burrows of which yielded two species of sandfly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10798109     DOI: 10.1007/bf02727165

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  4 in total

1.  Renal involvement in kala-azar.

Authors:  L S Prasad; S Sen; S K Ganguly
Journal:  Indian J Med Res       Date:  1992-01       Impact factor: 2.375

2.  Use of modified Grace's insect medium for the primary isolation of Leishmania donovani donovani in Bihar, India.

Authors:  R Saran; A K Gupta; S N Shrivastava; L S Prasad
Journal:  Am J Trop Med Hyg       Date:  1986-05       Impact factor: 2.345

3.  Migration of Leishmania donovani amastigotes in the cerebrospinal fluid.

Authors:  L S Prasad; S Sen
Journal:  Am J Trop Med Hyg       Date:  1996-12       Impact factor: 2.345

4.  An analysis of T cell responsiveness in Indian kala-azar.

Authors:  D L Sacks; S L Lal; S N Shrivastava; J Blackwell; F A Neva
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

  4 in total
  1 in total

1.  IN VIVO AND IN VITRO ANTILEISHMANIAL EFFECTS OF METHANOLIC EXTRACT FROM BARK OF BURSERA APTERA.

Authors:  O J Nieto-Yañez; A A Resendiz-Albor; P A Ruiz-Hurtado; N Rivera-Yañez; M Rodriguez-Canales; M Rodriguez-Sosa; I Juarez-Avelar; M G Rodriguez-Lopez; M M Canales-Martinez; M A Rodriguez-Monroy
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.